Zhaoke Ophthalmology (HKSE:06622) Short Percentage of Float

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

HKSE:06622 Zhaoke Ophthalmology Ltd HKSE:06622
47 GF Score
Price HK$2.53
GF Value HK$2.60
Valuation Fairly Valued
! 5 Warning Signs
View Full Analysis

What is Zhaoke Ophthalmology Short Percentage of Float?

Short Percentage of Float is the percentage of shares shorted compared to the float.

Due to the license agreement change with our data vendor, Short Interest related data on GuruFocus will no longer be updated. Existing data will remain as-is, while new data will not be available, except for certain Australian and Canadian stocks.

HKSE:06622 vs VRTX, REGN, MRNA: Short Percentage of Float Comparison

For the Biotechnology subindustry, Zhaoke Ophthalmology's Short Percentage of Float, along with its competitors' market caps and Short Percentage of Float data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Zhaoke Ophthalmology Short Percentage of Float vs Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Zhaoke Ophthalmology's Short Percentage of Float distribution charts can be found below:

* The bar in red indicates where Zhaoke Ophthalmology's Short Percentage of Float falls into.


HKSE:06622
47GF Score
Zhaoke Ophthalmology Ltd HKSE:06622
Short Percentage of Float is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Zhaoke Ophthalmology (HKSE:06622) Overvalued in 2026?

Based on GuruFocus' analysis, Zhaoke Ophthalmology stock appears to be undervalued. The current stock price of HK$2.53 is trading 2.7% below its estimated GF Value™ of HK$2.60. GuruFocus considers Zhaoke Ophthalmology to be Fairly Valued.

Key valuation signals for HKSE:06622:

  • Short Percentage of Float:
  • GF Value™: HK$2.60 vs. price of HK$2.53 (2.7% below fair value)
  • GF Score™: 47/100 with 5 warning signs

No single metric tells the full story. See the HKSE:06622 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Zhaoke Ophthalmology Business Description

Other Exchanges 9FX:Germany
Address No. 1 Meide 3rd Road, Pearl River Industrial Park, Nansha District, Guangdong Province, Guangzhou, CHN
Zhaoke Ophthalmology Ltd is an ophthalmic pharmaceutical company dedicated to the research, development, manufacture and commercialization of therapies that address unmet medical needs. The company has three flagship drug assets progressing towards potential market approval: NVK002 for myopia, CsA Ophthalmic Gel for DED and TAB014 for wAMD; and two drug assets in the clinical stage BRIMOCHOL PF for presbyopia and ZKY001 for corneal epithelial defects. Geographically the company operates in Hong Kong, Chinese Mainland, South Korea, and Others, of which it generates maximum revenue from Chinese Mainland.
47GF Score

Get the complete analysis for HKSE:06622

Short Percentage of Float is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

HK$2.53
Price
HK$2.60
GF Value